Table 3 Distribution and characteristics of subjects by region

Gender

Male (%)

17

(53.1)

41

(66.1)

26

(57.8)

33

(37.9)

29

(52.7)

219

(50.8)

0.028

Female (%)

15

(46.9)

21

(33.9)

19

(42.2)

54

(62.1)

26

(47.3)

212

(49.2)

Age

<65 (%)

13

(40.6)

40

(64.5)

24

(53.3)

48

(55.2)

28

(50.9)

184

(42.7)

0.012

≧65 (%)

19

(59.4)

22

(35.5)

21

(46.7)

39

(44.8)

27

(49.1)

247

(57.3)

Route of admission

Elective (%)

27

(84.4)

51

(82.3)

39

(86.7)

75

(86.2)

48

(87.3)

383

(88.9)

0.740

Urgent (%)

5

(15.6)

11

(17.7)

6

(13.3)

12

(13.8)

7

(12.7)

48

(11.1)

Hospital function

Community (%)

27

(84.4)

33

(53.2)

31

(68.9)

72

(82.8)

32

(58.2)

345

(80.0)

<0.001

Academic (%)

5

(15.6)

29

(46.8)

14

(31.1)

15

(17.2)

23

(41.8)

86

(20.0)

Comobidity

Absent (%)

18

(56.3)

36

(58.1)

25

(55.6)

50

(57.5)

35

(56.3)

260

(60.3)

0.950

Present (%)

14

(43.8)

26

(41.9)

20

(44.4)

37

(42.5)

20

(43.8)

171

(39.7)

Therapy

Chemotherapy (%)

30

(93.8)

51

(82.3)

40

(88.9)

66

(75.9)

53

(96.4)

408

(94.7)

<0.001

BMT (%)

2

(6.3)

11

(17.7)

5

(11.1)

21

(24.1)

2

(3.6)

23

(5.3)

Outcome

In hospital mortality (IQR)

8

(25.0)

8

(12.903)

7

(15.6)

15

(17.2)

13

(23.6)

91

(21.1)

0.519

0.519 Length of stay (IQR)

40

(59.0)

50

(61.0)

39

(50.0)

48

(63.0)

35

(34.0)

32

(47.0)

<0.001^a

0.001a Total cost ($) (IQR)

1497.7

(1944.6)

2082.8

(5244.6)

1594.2

(3221.1)

1761.2

(5612.5)

1282.2

(2126.0)

1304.6

(1779.2)

<0.001^a